H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report)’s stock price crossed below its 50-day moving average during trading on Thursday. The stock has a 50-day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares.
H. Lundbeck A/S Price Performance
The company’s fifty day moving average is $22.00 and its two-hundred day moving average is $22.00. The company has a quick ratio of 0.71, a current ratio of 1.15 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S is a Denmark-based pharmaceutical company focused on researching, developing and commercializing treatments for disorders of the brain. Its activities center on neuroscience, with therapeutic areas including depression, schizophrenia, migraine, Alzheimer’s disease, Parkinson’s disease and alcohol dependence.
The company’s portfolio includes prescription medicines such as Rexulti (brexpiprazole) for certain psychiatric disorders, Trintellix (vortioxetine) for major depressive disorder and Vyepti (eptinezumab) for migraine prevention.
Recommended Stories
- Five stocks we like better than H. Lundbeck A/S
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
